Rovin Capital UT ADV Purchases New Shares in The Clorox Company (NYSE:CLX)

Rovin Capital UT ADV acquired a new position in shares of The Clorox Company (NYSE:CLX) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 2,410 shares of the company’s stock, valued at approximately $393,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Nordea Investment Management AB increased its stake in shares of Clorox by 4.5% in the 1st quarter. Nordea Investment Management AB now owns 9,977 shares of the company’s stock valued at $1,519,000 after buying an additional 426 shares during the period. Texas Permanent School Fund Corp boosted its stake in Clorox by 1.8% in the first quarter. Texas Permanent School Fund Corp now owns 25,636 shares of the company’s stock valued at $3,925,000 after acquiring an additional 455 shares during the last quarter. Empirical Finance LLC grew its holdings in Clorox by 3.5% during the 1st quarter. Empirical Finance LLC now owns 4,457 shares of the company’s stock worth $682,000 after acquiring an additional 152 shares during the period. Envestnet Portfolio Solutions Inc. lifted its stake in shares of Clorox by 13.3% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 24,567 shares of the company’s stock valued at $3,761,000 after purchasing an additional 2,880 shares during the period. Finally, Empowered Funds LLC boosted its position in shares of Clorox by 8.4% in the 1st quarter. Empowered Funds LLC now owns 20,008 shares of the company’s stock worth $3,063,000 after purchasing an additional 1,558 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.57% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on CLX shares. BNP Paribas raised Clorox to a “strong sell” rating in a research note on Friday, September 6th. DA Davidson lifted their target price on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Citigroup increased their price objective on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and increased their target price for the stock from $155.00 to $170.00 in a report on Wednesday. Five analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $155.00.

Clorox Trading Up 1.5 %

CLX stock opened at $165.20 on Friday. The stock has a market cap of $20.45 billion, a price-to-earnings ratio of 57.56, a price-to-earnings-growth ratio of 3.02 and a beta of 0.41. The company has a fifty day moving average price of $162.14 and a two-hundred day moving average price of $146.83. The Clorox Company has a one year low of $127.60 and a one year high of $169.09. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.49 earnings per share. Equities analysts anticipate that The Clorox Company will post 6.81 EPS for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.95%. The ex-dividend date was Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 170.04%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.